Medartis Holding AG (SIX: MED.SW) Stock Competitors & Peer Comparison

Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 1.1B. In comparison, ABT.SW has a market cap of 125.5B. Regarding current trading prices, MED.SW is priced at CHF 86.50 on the SIX, while ABT.SW trades at CHF 72.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 72.08, whereas ABT.SW's P/E ratio is 19.79. In terms of profitability, MED.SW's ROE is +0.05%, compared to ABT.SW's ROE of +0.11%. Regarding short-term risk, MED.SW is more volatile compared to ABT.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check ABT.SW's competition here

Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 1.1B. In comparison, ZBH.SW has a market cap of 15B. Regarding current trading prices, MED.SW is priced at CHF 86.50 on the SIX, while ZBH.SW trades at CHF 77.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 72.08, whereas ZBH.SW's P/E ratio is 12.53. In terms of profitability, MED.SW's ROE is +0.05%, compared to ZBH.SW's ROE of +0.06%. Regarding short-term risk, MED.SW is more volatile compared to ZBH.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check ZBH.SW's competition here

Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 1.1B. In comparison, SOON.SW has a market cap of 14.1B. Regarding current trading prices, MED.SW is priced at CHF 86.50 on the SIX, while SOON.SW trades at CHF 237.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 72.08, whereas SOON.SW's P/E ratio is 26.04. In terms of profitability, MED.SW's ROE is +0.05%, compared to SOON.SW's ROE of +0.17%. Regarding short-term risk, MED.SW is more volatile compared to SOON.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check SOON.SW's competition here

Medartis Holding AG (SIX: MED.SW) plays a significant role within the Healthcare sector. Its performance on the SIX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 1.1B. In comparison, METN.SW has a market cap of 387.5M. Regarding current trading prices, MED.SW is priced at CHF 86.50 on the SIX, while METN.SW trades at CHF 865.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 72.08, whereas METN.SW's P/E ratio is -35.95. In terms of profitability, MED.SW's ROE is +0.05%, compared to METN.SW's ROE of -0.03%. Regarding short-term risk, MED.SW is more volatile compared to METN.SW. This indicates higher risk in terms of short-term price fluctuations for MED.SW.Check METN.SW's competition here